International Agencies

These guidelines have been developed to assist national TB control programs (NTPs) in adopting specific anti-TB drug resistance surveillance systems to measure susceptibility to first-line TB drugs.

This is an achievement report about the Global Drug Facility (GDF), a key initiative of the STOP TB Partnership, which has had a positive impact on the treatment of millions of TB patients globally since its establishment in 2001. By providing high-quality TB drugs to over 4.4 million people in some of the world's poorest countries, it has helped to save lives and has significantly strengthened global TB control efforts.

This poster, available in high- and low-resolution, raises worldwide awareness about the international health threat posed by tuberculosis. The focus of the Stop TB Partnership Secretariat for World TB Day 2005 is the crucial role of frontline TB care providers in the fight against TB.

This fact sheet summarizes global goals and targets for TB control. The fact sheet also contains a data table with demographic, epidemiological, and operational indicators; threats to TB control; and resources for all the countries in the Americas.

This fact sheet provides an overview of TB diagnosis, treatment, and drug-resistant TB. It also reviews the Medecins Sans Frontieres (MSF), campaign for Access to Essential Medicines, which has dealt with TB since its first day of operations more than 30 years ago.

This report developed by the World Health Organization (WHO) describes a strategy to integrate management of respiratory conditions to improve TB case detection. The PAL aims to improve TB diagnosis and care by improving (1) the quality of respiratory care in primary health care (PHC) settings, and (2) the efficiency of respiratory service delivery within health systems.

The "10/90 Gap" is the idea that only 10% of global health research is devoted to conditions accounting for 90% of the global disease burden.
This report dispels the myth of the 10/90 Gap in health research including research regarding tuberculosis. It calls for a more constructive approach to improving access to medicines for the poor.

The Patient's Charter for Tuberculosis Care (The Charter) outlines the rights and responsibilities of people with tuberculosis. It empowers people with the disease and their communities through this knowledge. Initiated and developed by patients from around the world, the Charter makes the relationship with health care providers a mutually beneficial one. The Charter is affiliated with the International Standards for Tuberculosis Care, developed by the Tuberculosis Coalition for Technical Assistance.

These guidelines offer recommendations for TB control programmes and medical workers in middle- and low- income countries faced with drug-resistant forms of TB, especially MDR-TB.

This fact sheet provides information on the global burden of TB, TB targets, and the new Stop TB Strategy.